Masarykův onkologický ústav; Klinika komplexní onkologické péče
About Masarykův onkologický ústav; Klinika komplexní onkologické péče
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Bristol-Myers Squibb
5
Institut de Recherches Internationales Servier
1
Clinical Trials at Masarykův onkologický ústav; Klinika komplexní onkologické péče
During the past decade, Masarykův onkologický ústav; Klinika komplexní onkologické péče conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer
2015-09-14
2022-08-22
Completed
803
Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
2016-10-20
2022-03-11
Completed
425
An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma
2017-04-11
2021-02-02
Completed
1,844
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
2018-01-06
2023-01-04
Completed
580
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
2018-10-16
2024-12-01
Active, not recruiting
274
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
2019-02-28
2028-07-05
Recruiting
1,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Masarykův onkologický ústav; Klinika komplexní onkologické péče"
#1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Masarykův onkologický ústav; Klinika komplexní onkologické péče
According to Clinical.Site data, the most researched conditions in "Masarykův onkologický ústav; Klinika komplexní onkologické péče" are
"Breast Cancer" (2 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Breast Neoplasms" (1 trials), "Cancer" (1 trials) and "Cancer of the Stomach" (1 trials). Many other conditions were trialed in "Masarykův onkologický ústav; Klinika komplexní onkologické péče" in a lesser frequency.
Clinical Trials Intervention Types at Masarykův onkologický ústav; Klinika komplexní onkologické péče
Most popular intervention types in "Masarykův onkologický ústav; Klinika komplexní onkologické péče" are "Drug" (11 trials), "Biological" (5 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Nivolumab" (5 trials), "Atezolizumab" (3 trials), "Placebo" (3 trials), "Ipatasertib" (2 trials) and "Ipilimumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Masarykův onkologický ústav; Klinika komplexní onkologické péče
The vast majority of trials in "Masarykův onkologický ústav; Klinika komplexní onkologické péče" are
14 trials for "All" genders.
Clinical Trials Status at Masarykův onkologický ústav; Klinika komplexní onkologické péče
Currently, there are NaN active trials in "Masarykův onkologický ústav; Klinika komplexní onkologické péče".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Masarykův onkologický ústav; Klinika komplexní onkologické péče,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Masarykův onkologický ústav; Klinika komplexní onkologické péče, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".